Listed

Equillium, Inc.

EQNasdaqCIK 1746466HealthcareFiscal year ends Dec 31

Reports and events: 158 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Equillium, Inc., Reports and events
FiledFormWhat it isAccession number
2024-02-2206:08 ET8-K8.01 Other events0001193125-24-041994
2023-12-2108:05 ET8-K8.01 Other events0001193125-23-300417
2023-11-0816:10 ET10-QQuarterly reportPeriod 2023-09-300000950170-23-061108
2023-11-0816:05 ET8-K2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits0000950170-23-061084
2023-10-1608:05 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-23-256538
2023-10-0517:28 ET8-K1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 3.01 Delisting notice; 9.01 Financial statements and exhibits0001193125-23-251681
2023-08-0916:11 ET10-QQuarterly reportPeriod 2023-06-300000950170-23-040583
2023-08-0916:06 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-23-040564
2023-05-2516:00 ET8-K1.02 Termination of a material agreement0001193125-23-154186
2023-05-2316:02 ET8-K5.07 Shareholder vote results0001193125-23-151783
2023-05-1116:11 ET10-QQuarterly reportPeriod 2023-03-310000950170-23-021236
2023-05-1116:06 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-23-021215
2023-04-1116:01 ETDEF 14AProxy statementPeriod 2023-05-220001193125-23-097790
2023-04-0616:02 ET8-K3.01 Delisting notice0001193125-23-093949
2023-03-2316:13 ET10-KAnnual reportPeriod 2022-12-310000950170-23-009492
2023-03-2316:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-23-077853
2022-12-2316:11 ET8-K1.02 Termination of a material agreement; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-22-311788
2022-12-1521:49 ET8-K8.01 Other events0001193125-22-305076
2022-12-0607:00 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-22-298869
2022-11-1417:17 ET10-QQuarterly reportPeriod 2022-09-300000950170-22-025052
2022-11-1416:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-22-024988
2022-09-2709:28 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-22-251807
2022-09-2617:27 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-22-251386
2022-09-0616:29 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-22-238883
2022-08-1516:50 ET10-QQuarterly reportPeriod 2022-06-300000950170-22-017399
2022-08-1516:22 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-22-017382
2022-05-2516:57 ET8-K5.07 Shareholder vote results0001193125-22-159792
2022-05-1216:12 ET10-QQuarterly reportPeriod 2022-03-310000950170-22-009669
2022-05-1216:07 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-22-009653
2022-05-0908:06 ET8-K8.01 Other events0001193125-22-144343
2022-05-0213:19 ET8-K/A9.01 Financial statements and exhibits0000950170-22-006823
2022-04-2508:05 ET8-K8.01 Other events0001193125-22-116380
2022-04-1316:06 ETDEF 14AProxy statementPeriod 2022-05-240001193125-22-104267
2022-03-2316:09 ET10-KAnnual reportPeriod 2021-12-310000950170-22-004407
2022-03-2316:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-22-004404
2022-03-0414:00 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000950170-22-002895
2022-03-0209:00 ET8-K5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits0000950170-22-002622
2022-02-1607:01 ET8-K1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-22-043939
2021-11-1016:11 ET10-QQuarterly reportPeriod 2021-09-300000950170-21-004079
2021-11-1016:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-21-004068
2021-08-1016:16 ET10-QQuarterly reportPeriod 2021-06-300000950170-21-001180
2021-08-1016:11 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-21-001177
2021-07-1216:00 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000950170-21-000445
2021-06-1415:57 ET8-K8.01 Other events0000950170-21-000348
2021-06-1107:00 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000950170-21-000344
2021-06-1011:13 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000950170-21-000338
2021-06-0715:13 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000950170-21-000318
2021-05-2809:05 ET8-K5.07 Shareholder vote results0000950123-21-007391
2021-05-1316:16 ET10-QQuarterly reportPeriod 2021-03-310000950170-21-000224
2021-05-1316:13 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-21-000223

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 19:43 ET. Listed shows no prices and gives no investment advice.